Proteomics

Dataset Information

0

Molecular Signatures of Preeclampsia and Gestational Diabetes Mellitus Utilizing Multi-Omics Analyses, Part 1


ABSTRACT: The application of multi-omic evaluations, multi-dimensional analysis methods, and new cheminformatics-based visualization tools to provide an in depth understanding of the molecular changes taking place in preeclampsia (PRE) and gestational diabetes mellitus (GDM) patients. Since PRE and GDM are two prevalent pregnancy complications that result in adverse health effects for both the mother and fetus during pregnancy and later in life, a better understanding of each is essential. The multi-omic evaluations performed here provide new insight into the end-stage molecular profiles of each disease, thereby supplying crucial information for earlier diagnosis and potential treatments. For the Proteomics_PooledFractions datasets, peptide samples were pooled by condition and fractionated offline into 24 samples; each fraction was run via Q Exactive and Ion Mobility Mass Spectrometry for creation of an AMT tag database. Proteomics_Samples contains datasets from peptide samples that were run via Ion Mobility Mass Spectrometry. Lipidomics_Samples contains datasets from lipid samples that were run via LTQ Orbitrap Velos Mass Spectrometry.

INSTRUMENT(S): LTQ Orbitrap Velos, 6510 Quadrupole Time-of-Flight LC/MS, Q Exactive Plus

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Erin S. Baker   Kristin E. Burnum-Johnson  

PROVIDER: MSV000085357 | MassIVE | Fri May 01 17:28:00 BST 2020

REPOSITORIES: MassIVE

altmetric image

Publications

Unveiling molecular signatures of preeclampsia and gestational diabetes mellitus with multi-omics and innovative cheminformatics visualization tools.

Odenkirk Melanie T MT   Stratton Kelly G KG   Gritsenko Marina A MA   Bramer Lisa M LM   Webb-Robertson Bobbie-Jo M BM   Bloodsworth Kent J KJ   Weitz Karl K KK   Lipton Anna K AK   Monroe Matthew E ME   Ash Jeremy R JR   Fourches Denis D   Taylor Brandie D BD   Burnum-Johnson Kristin E KE   Baker Erin S ES  

Molecular omics 20200923 6


To fully enable the development of diagnostic tools and progressive pharmaceutical drugs, it is imperative to understand the molecular changes occurring before and during disease onset and progression. Systems biology assessments utilizing multi-omic analyses (e.g. the combination of proteomics, lipidomics, genomics, etc.) have shown enormous value in determining molecules prevalent in diseases and their associated mechanisms. Herein, we utilized multi-omic evaluations, multi-dimensional analysi  ...[more]

Similar Datasets

2020-05-02 | MSV000085361 | MassIVE
2023-09-04 | GSE241900 | GEO
| PRJNA430481 | ENA
| PRJNA430482 | ENA
2022-08-01 | GSE209878 | GEO
2021-04-21 | GSE165255 | GEO
2020-08-28 | GSE157003 | GEO
2020-03-26 | PXD016519 | Pride
2023-08-28 | BIOMD0000001075 | BioModels
2023-09-01 | PXD045065 | iProX